President Donald Trump signed an executive order the White House says is aimed at "lowering drug prices and stopping foreign free-riding on American pharmaceutical innovation."

Emily Field, head of European pharmaceutical research at Barclays, says U.S. President Donald Trump's executive order on drug pricing marks the start of negotiations with pharmaceutical companies.

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries that suppress drug prices.